Welcome to Industry Focus. The Podcast that dives into a different sector of the stock market each day.

I'm your host Emily Flippin. I'm Jason Moser. I'm Nick Seidful. I'm

Dylan Lewis. And today we're talking financials. Today we're talking

consumer goods. Wild-Carp! Wednesday. And we're talking energy. And today we're talking tech. Let's dive in.

Welcome Industry Focus, I'm Nick Saipol. On today's episode we're updating the story on Blue

Gene stocks, which we last discussed on

our November 26th 2019 episode and we'll be taking a look at how the coronavirus is

impacting retail returning to the podcast to help me break it all down as a

Motley Fool contributor Osset Sharma.

Osset, welcome back on the podcast.

Thanks a lot, Nick.

I'm excited to be back and of course this is a podcast so you can't see but

I'm wearing my favorite pair of blue jeans to talk blue jeans today.

We all are right it's 2020 I don't know when anybody has dressed up this year I just

just let folks know so we're pre-recording this episode on

November 23rd. It's the week of Thanksgiving. So we're recording this a little

bit early and just one extra programming note there will be no

industry focus podcast on Thursday because of Thanksgiving.

But today, as I said, we're talking a little bit about how coronavirus is impacting retail.

And obviously everybody has seen the news these past a couple weeks we've had two vaccine candidates one from Pfizer one from Moderna I believe there was another one that came out to today on Monday from Oxford.

So lots of great news about and folks really positive about this idea that maybe towards the end of next year,

we can have a vaccine with wide distribution that's effective.

...